股票行情快报：蓝帆医疗（002382）8月25日主力资金净卖出1037.63万元

Core Viewpoint - Bluefan Medical (002382) shows a mixed performance in stock price and fund flow, with a slight increase in stock price but significant net outflows from major funds [1][2]. Fund Flow Summary - On August 25, 2025, Bluefan Medical's stock closed at 6.52 CNY, up 1.4%, with a turnover rate of 3.14% and a trading volume of 314,300 hands, resulting in a transaction amount of 204 million CNY [1]. - The fund flow data indicates a net outflow of 10.38 million CNY from major funds, accounting for 5.09% of the total transaction amount, while retail funds saw a net inflow of 14.35 million CNY, representing 7.04% of the total [1][2]. - Over the past five days, the stock experienced fluctuations in fund flows, with notable net inflows and outflows from different investor categories [2]. Company Performance Metrics - As of the latest report, Bluefan Medical has a total market value of 6.566 billion CNY, with a net asset value of 10.102 billion CNY, and a net profit of 77.0223 million CNY [3]. - The company’s price-to-earnings ratio (P/E) stands at 21.31, significantly lower than the industry average of 75.1, while the price-to-book ratio (P/B) is 0.81, compared to the industry average of 4.05 [3]. - The gross margin is reported at 17.17%, which is considerably lower than the industry average of 51.32%, and the net profit margin is 5.58%, below the industry average of 10.74% [3]. - In the first quarter of 2025, Bluefan Medical reported a main business revenue of 1.478 billion CNY, a year-on-year increase of 1.59%, and a net profit attributable to shareholders of 77.0223 million CNY, a significant year-on-year increase of 177.86% [3].